These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2510584)
1. Vinblastine-C4 alkyl maleoyl and amino acid maleoyl derivatives: III. Experimental antitumor activities of lactosaminated serum albumin conjugates. Rao KS; Collard MP; Cornet J; Trouet A Anticancer Res; 1989; 9(4):973-9. PubMed ID: 2510584 [TBL] [Abstract][Full Text] [Related]
2. Vinblastine-C4 alkyl maleoyl and amino acid maleoyl derivatives. II. Experimental antitumor activity against leukemias and human tumor xenografts. Collard MP; Rao KS; Trouet A Anticancer Res; 1989; 9(3):625-30. PubMed ID: 2764509 [TBL] [Abstract][Full Text] [Related]
3. Vinblastine-C4 alkyl maleoyl and amino acid maleoyl derivatives: I. Chemistry and physicochemical data. Rao KS; Hannart JA; Trouet A Anticancer Res; 1989; 9(3):619-24. PubMed ID: 2764508 [TBL] [Abstract][Full Text] [Related]
4. Vinca-23-oyl amino acid derivatives: as new anticancer agents (review). Bhushana Rao KS; Collard MP; Trouet A Anticancer Res; 1985; 5(4):379-86. PubMed ID: 3898995 [TBL] [Abstract][Full Text] [Related]
5. [New antitumor derivatives of vinblastine]. Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug. Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of L/1C2-4-desacetylvinblastine-3-carboxhydrazide immunoconjugate in xenografts. Johnson DA; Baker AL; Laguzza BC; Fix DV; Gutowski MC Cancer Res; 1990 Mar; 50(6):1790-4. PubMed ID: 2306731 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related]
9. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors. Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285 [TBL] [Abstract][Full Text] [Related]
10. New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies. Orosz F; Comin B; Raïs B; Puigjaner J; Kovács J; Tárkányi G; Acs T; Keve T; Cascante M; Ovádi J Br J Cancer; 1999 Mar; 79(9-10):1356-65. PubMed ID: 10188876 [TBL] [Abstract][Full Text] [Related]
11. Effect of desacetyl vinblastine amide (DVA) against human sarcomas heterotransplanted in nude mice. Sordillo PP; Hajdu SI; Magill GB; Lesser M; Helson L Cancer Clin Trials; 1980; 3(4):391-4. PubMed ID: 7428143 [TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of the antitumor action of spirobromine in mice with leukemia P-388]. Sokolova IS; Riabokon' NA; Chernov VA; Gorbacheva LB Izv Akad Nauk SSSR Biol; 1989; (5):660-5. PubMed ID: 2584530 [TBL] [Abstract][Full Text] [Related]
13. New alpha-amino phosphonic acid derivatives of vinblastine: chemistry and antitumor activity. Lavielle G; Hautefaye P; Schaeffer C; Boutin JA; Cudennec CA; Pierré A J Med Chem; 1991 Jul; 34(7):1998-2003. PubMed ID: 2066973 [TBL] [Abstract][Full Text] [Related]
14. Advances in vinca-alkaloids: Navelbine. Marty M; Extra JM; Espie M; Leandri S; Besenval M; Krikorian A Nouv Rev Fr Hematol (1978); 1989; 31(2):77-84. PubMed ID: 2671933 [TBL] [Abstract][Full Text] [Related]
15. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid. Kruczynski A; Colpaert F; Tarayre JP; Mouillard P; Fahy J; Hill BT Cancer Chemother Pharmacol; 1998; 41(6):437-47. PubMed ID: 9554586 [TBL] [Abstract][Full Text] [Related]
16. [Hemisynthesis of antineoplastic conjugates with nitrogen-mustard proteins]. Smolders RR; Jacquemotte F; Godart S; Legentil I J Pharm Belg; 1990; 45(3):184-90. PubMed ID: 2401950 [TBL] [Abstract][Full Text] [Related]
17. Antitumor xenograft activity with a conjugate of a Vinca derivative and the squamous carcinoma-reactive monoclonal antibody PF1/D. Johnson DA; Laguzza BC Cancer Res; 1987 Jun; 47(12):3118-22. PubMed ID: 3495327 [TBL] [Abstract][Full Text] [Related]
18. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives. Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935 [TBL] [Abstract][Full Text] [Related]
19. Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity. Bacherikov VA; Chou TC; Dong HJ; Zhang X; Chen CH; Lin YW; Tsai TJ; Lee RZ; Liu LF; Su TL Bioorg Med Chem; 2005 Jun; 13(12):3993-4006. PubMed ID: 15911312 [TBL] [Abstract][Full Text] [Related]
20. Vinblastin-23-oyl amino acid derivatives: chemistry, physicochemical data, toxicity, and antitumor activities against P388 and L1210 leukemias. Bhushana Rao KS; Collard MP; Dejonghe JP; Atassi G; Hannart JA; Trouet A J Med Chem; 1985 Aug; 28(8):1079-88. PubMed ID: 4020828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]